| Serial Number | 90191738 |
| Word Mark | ADCT |
| Filing Date | Friday, September 18, 2020 |
| Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
| Status Date | Wednesday, October 8, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, May 24, 2022 |
| Goods and Services | Pharmaceutical preparations and substances for use in oncology; pharmaceutical preparations for use in the prevention and treatment of cancer and tumors; pharmaceutical preparations for use in the prevention and treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, pharmaceutical antibodies; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations, biological preparations, and gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans |
| Goods and Services | Providing medical information; providing information in the fields of healthcare, therapeutic properties of pharmaceuticals, health, and wellness |
| Goods and Services | Pharmaceutical drug development services; providing medical and scientific research information in the field of pharmaceuticals; Providing medical and scientific research information in the fields of clinical trials; scientific study and research in the field of pharmaceuticals for the treatment of cancer |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 28, 2020 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 28, 2020 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, October 28, 2020 |
| Primary Code | 044 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | ADC Therapeutics SA |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 99 - Other |
| Address | Epalinges 1066 CH |
| Party Name | ADC Therapeutics SA |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 99 - Other |
| Address | Epalinges 1066 CH |
| Event Date | Event Description |
| Tuesday, February 2, 2021 | ASSIGNED TO EXAMINER |
| Wednesday, February 3, 2021 | NON-FINAL ACTION WRITTEN |
| Tuesday, August 3, 2021 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, August 3, 2021 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 22, 2020 | NEW APPLICATION ENTERED |
| Wednesday, October 28, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Wednesday, February 3, 2021 | NON-FINAL ACTION E-MAILED |
| Wednesday, February 3, 2021 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, August 3, 2021 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, October 6, 2021 | FINAL REFUSAL WRITTEN |
| Wednesday, April 6, 2022 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Tuesday, April 12, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, October 6, 2021 | FINAL REFUSAL E-MAILED |
| Wednesday, October 6, 2021 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Wednesday, April 6, 2022 | EXPARTE APPEAL RECEIVED AT TTAB |
| Wednesday, April 6, 2022 | EX PARTE APPEAL-INSTITUTED |
| Wednesday, April 6, 2022 | JURISDICTION RESTORED TO EXAMINING ATTORNEY |
| Monday, April 11, 2022 | ASSIGNED TO LIE |
| Tuesday, April 12, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Wednesday, January 18, 2023 | SOU EXTENSION 1 GRANTED |
| Wednesday, April 20, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Wednesday, April 20, 2022 | EXPARTE APPEAL TERMINATED |
| Wednesday, May 4, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Tuesday, May 24, 2022 | PUBLISHED FOR OPPOSITION |
| Tuesday, May 24, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, July 19, 2022 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Wednesday, January 18, 2023 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, January 18, 2023 | SOU EXTENSION 1 FILED |
| Friday, January 20, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 13, 2023 | SOU TEAS EXTENSION RECEIVED |
| Saturday, July 15, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, January 18, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Thursday, July 13, 2023 | SOU EXTENSION 2 FILED |
| Thursday, July 13, 2023 | SOU EXTENSION 2 GRANTED |
| Tuesday, January 16, 2024 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 16, 2024 | SOU EXTENSION 3 FILED |
| Tuesday, January 16, 2024 | SOU EXTENSION 3 GRANTED |
| Friday, July 12, 2024 | SOU TEAS EXTENSION RECEIVED |
| Friday, July 12, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Friday, July 12, 2024 | SOU EXTENSION 4 FILED |
| Wednesday, October 8, 2025 | ABANDONMENT - NO USE STATEMENT FILED |
| Wednesday, October 8, 2025 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
| Friday, July 12, 2024 | SOU EXTENSION 4 GRANTED |